Skip to main content

Table 1 Baseline characteristics

From: Correlation of circulating C1q and C1q-binding adiponectin concentrations with aging in males: a preliminary report

n (males) 509
Age, years 54±10 (30–100)
Body mass index (BMI), kg/m2 24.1±3.0 (14.8−36.5)
Hypertension, % (medication, %) 42.2 (23.8)
Systolic blood pressure (SBP), mmHg 123±12 (91–174)
Diastolic blood pressure (DBP), mmHg 78±8 (47–100)
Diabetes, % (medication, %) 33.6 (4.9)
Fasting blood glucose (FBG), mg/dL 109±18 (64–284)
Hemoglobin A1c (HbA1c), (NGSP), % 5.8±0.6 (4.5−10.2)
Estimated glomerular filtration rate (eGFR), mL/min 69.4±12.8 (28.6−130.5)
Dyslipidemia, % (medication, %) 40.9 (12.4)
Total cholesterol (T-cho), mg/dL 204±33 (104–332)
Triglyceride (TG), mg/dL 140±94 (35–871)
High-density lipoprotein-cholesterol (HDL-C), mg/dL 56±13 (27–97)
History of myocardial infarction, angina, stroke, heart failure, and renal failure, % 0.8/0.2/0.6/0.6/23.8
Smoking (none-/ex--/current-), % 26.2/48.0/25.8
Brinkman index 383±352 (0–2000)
Serum Total-APN, μg/mL 6.8±3.6 (1.1−34.8)
Serum HMW-APN, μg/mL 4.9±3.6 (0.2−32.3)
Serum C1q-APN, units/mL 67.8±19.8 (31.6−209.3)
Serum C1q, μg/mL 56.7±9.8 (17.3−84.2)
Serum HWM-APN/Total-APN ratio 0.7±0.2 (0.2−1.3)
Serum C1q-APN/Total-APN ratio 11.5±4.6 (2.6−44.3)
Serum C1q-APN/HMW-APN ratio 20.4±17.0 (2.8−225.3)
Serum C1q-APN/C1q ratio 1.2±0.5 (0.5−4.0)
  1. Data are mean±SD (range), or number of subjects.
  2. APN; adiponectin, HMW; high-molecular weight.